Vaxcell-Bio Therapeutics financial statements

박셀바이오KRX:323990 · KOSDAQ · Healthcare · sector #23
₩4,370-0.46%
2026-10-07 close

Vaxcell-Bio Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was KRW 1.9B. 2024 operating profit was −KRW 15.05B.

Reported results

Vaxcell-Bio Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy